Nuvation Bio Inc.
Price Action
Technical Summary
CONSOLIDATINGNuvation Bio Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 66), indicating performance broadly in line with the market. Earnings growth of 106% provides fundamental context to the price action. Investors should exercise caution due to high volatility (88% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $4.91 | +13.26% | ABOVE |
| 50 SMA | $4.79 | +16.02% | ABOVE |
| 100 SMA | $4.90 | +13.38% | ABOVE |
| 150 SMA | $5.79 | -4.01% | BELOW |
| 200 SMA | $5.32 | +4.48% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is NUVB in an uptrend right now?
NUVB has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is NUVB overbought or oversold?
NUVB's RSI (14) is 62. The stock is in neutral territory, neither overbought nor oversold.
Is NUVB outperforming the market?
NUVB has a Relative Strength (RS) Rating of 66 out of 99. NUVB is performing about average compared to the market.
Where is NUVB in its 52-week range?
NUVB is trading at $5.56, which is 57% of its 52-week high ($9.75) and 47% above its 52-week low ($1.81).
How volatile is NUVB?
NUVB has a Beta of 2.14 and 52-week volatility of 88%. It's more volatile than the S&P 500 - expect bigger swings.